IBDEI309 ; ; 04-FEB-2020
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,47993,0)
 ;;=I73.00^^185^2414^75
 ;;^UTILITY(U,$J,358.3,47993,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,47993,1,3,0)
 ;;=3^Raynaud's Syndrome w/o Gangrene
 ;;^UTILITY(U,$J,358.3,47993,1,4,0)
 ;;=4^I73.00
 ;;^UTILITY(U,$J,358.3,47993,2)
 ;;=^5007796
 ;;^UTILITY(U,$J,358.3,47994,0)
 ;;=R57.0^^185^2414^76
 ;;^UTILITY(U,$J,358.3,47994,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,47994,1,3,0)
 ;;=3^Shock,Cardiogenic
 ;;^UTILITY(U,$J,358.3,47994,1,4,0)
 ;;=4^R57.0
 ;;^UTILITY(U,$J,358.3,47994,2)
 ;;=^5019525
 ;;^UTILITY(U,$J,358.3,47995,0)
 ;;=R57.1^^185^2414^77
 ;;^UTILITY(U,$J,358.3,47995,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,47995,1,3,0)
 ;;=3^Shock,Hypovolemic
 ;;^UTILITY(U,$J,358.3,47995,1,4,0)
 ;;=4^R57.1
 ;;^UTILITY(U,$J,358.3,47995,2)
 ;;=^60845
 ;;^UTILITY(U,$J,358.3,47996,0)
 ;;=R57.9^^185^2414^78
 ;;^UTILITY(U,$J,358.3,47996,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,47996,1,3,0)
 ;;=3^Shock,Unspec
 ;;^UTILITY(U,$J,358.3,47996,1,4,0)
 ;;=4^R57.9
 ;;^UTILITY(U,$J,358.3,47996,2)
 ;;=^5019527
 ;;^UTILITY(U,$J,358.3,47997,0)
 ;;=R55.^^185^2414^79
 ;;^UTILITY(U,$J,358.3,47997,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,47997,1,3,0)
 ;;=3^Syncope and Collapse
 ;;^UTILITY(U,$J,358.3,47997,1,4,0)
 ;;=4^R55.
 ;;^UTILITY(U,$J,358.3,47997,2)
 ;;=^116707
 ;;^UTILITY(U,$J,358.3,47998,0)
 ;;=I78.0^^185^2414^80
 ;;^UTILITY(U,$J,358.3,47998,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,47998,1,3,0)
 ;;=3^Telangiectasia,Hereditary Hemorrhagic
 ;;^UTILITY(U,$J,358.3,47998,1,4,0)
 ;;=4^I78.0
 ;;^UTILITY(U,$J,358.3,47998,2)
 ;;=^117566
 ;;^UTILITY(U,$J,358.3,47999,0)
 ;;=I73.1^^185^2414^20
 ;;^UTILITY(U,$J,358.3,47999,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,47999,1,3,0)
 ;;=3^Buerger's Disease
 ;;^UTILITY(U,$J,358.3,47999,1,4,0)
 ;;=4^I73.1
 ;;^UTILITY(U,$J,358.3,47999,2)
 ;;=^5007798
 ;;^UTILITY(U,$J,358.3,48000,0)
 ;;=G45.9^^185^2414^81
 ;;^UTILITY(U,$J,358.3,48000,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,48000,1,3,0)
 ;;=3^Transient Cerebral Ischemic Attack,Unspec
 ;;^UTILITY(U,$J,358.3,48000,1,4,0)
 ;;=4^G45.9
 ;;^UTILITY(U,$J,358.3,48000,2)
 ;;=^5003959
 ;;^UTILITY(U,$J,358.3,48001,0)
 ;;=G45.8^^185^2414^82
 ;;^UTILITY(U,$J,358.3,48001,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,48001,1,3,0)
 ;;=3^Transient Cerebral Ischemic Attacks & Related Syndromes
 ;;^UTILITY(U,$J,358.3,48001,1,4,0)
 ;;=4^G45.8
 ;;^UTILITY(U,$J,358.3,48001,2)
 ;;=^5003958
 ;;^UTILITY(U,$J,358.3,48002,0)
 ;;=I83.019^^185^2414^85
 ;;^UTILITY(U,$J,358.3,48002,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,48002,1,3,0)
 ;;=3^Varicose Veins Right Lower Extrem w/ Ulcer Unspec Site
 ;;^UTILITY(U,$J,358.3,48002,1,4,0)
 ;;=4^I83.019
 ;;^UTILITY(U,$J,358.3,48002,2)
 ;;=^5007979
 ;;^UTILITY(U,$J,358.3,48003,0)
 ;;=I83.899^^185^2414^83
 ;;^UTILITY(U,$J,358.3,48003,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,48003,1,3,0)
 ;;=3^Varicose Veins Lower Extrem w/ Other Complications
 ;;^UTILITY(U,$J,358.3,48003,1,4,0)
 ;;=4^I83.899
 ;;^UTILITY(U,$J,358.3,48003,2)
 ;;=^5008018
 ;;^UTILITY(U,$J,358.3,48004,0)
 ;;=I83.90^^185^2414^84
 ;;^UTILITY(U,$J,358.3,48004,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,48004,1,3,0)
 ;;=3^Varicose Veins Lower Extrem,Asymptomatic
 ;;^UTILITY(U,$J,358.3,48004,1,4,0)
 ;;=4^I83.90
 ;;^UTILITY(U,$J,358.3,48004,2)
 ;;=^5008019
 ;;^UTILITY(U,$J,358.3,48005,0)
 ;;=I87.2^^185^2414^86
